🔍 Key Findings

• FGPP (fluoroscopic-guided percutaneous pinning) resulted in successful healing in 10/13 fractures, with good limb function.
• Complications occurred in 5 of 11 cases, including intra-articular implants, malunion, implant failure/nonunion, and implant migration.
• Cases with delayed surgery (>15 days) or radiographic remodeling were more likely to experience major complications.
• Most fractures (10/13) were classified as Salter-Harris type I with mild displacement.
• Median surgical time was 60 minutes, and no conversions to open surgery were needed.
• Postoperative femoral neck resorption was minimal, suggesting possible benefits of the minimally invasive approach for preserving vascular supply.
• One intra-articular pin led to progressive joint disease and required femoral head ostectomy.
• FGPP appears best suited for acute, minimally displaced fractures in young dogs (<8 months) with planned elective explant to avoid growth disturbance.

🔍 Key Findings

• Portal pressure increased proportionally with insufflation pressure: 38% at 6 mmHg, 95% at 10 mmHg, and 175% at 14 mmHg.
• Exponential model: average increase of 7.45% per mmHg of insufflation pressure (CI: 4.7–10.2%).
• No systemic hemodynamic adverse effects were observed; MAP remained >60 mmHg throughout.
• Portal hypertension threshold (15 mmHg) predicted at ~6.4 mmHg insufflation pressure.
• No statistical impact from patient weight, pressure-to-weight ratio, or order of insufflation rounds.
• Measurement technique was feasible and safe, with only minor challenges (e.g., catheter kinking).
• The study supports use of the lowest insufflation pressure needed for visualization to avoid portal hypertension.
• Baseline portal pressures returned after desufflation, supporting comparison pre- and post-attenuation.

🔍 Key Findings

Study population: 12 dogs with medial or lateral tarsocrural joint instability (TCI), including 5 working farm dogs.
Procedure: Temporary immobilization using a calcaneotibial screw (CTS) combined with external coaptation (EC).
Stabilization techniques:

• 3 dogs = primary ligamentous repair
• 8 dogs = synthetic ligament reconstruction
• 2 dogs = malleolar fracture repair

Follow-up: Median 31 months (range 4–66); 10 owners completed outcome survey.
Outcomes:

• All 10 dogs had improved or resolved lameness.
• All 5 farm dogs returned to work (most at full or substantial capacity).
• Complication rate: 4 distinct events in 3 dogs (1 major = CTS breakage; 3 minor = bandage-related soft tissue injuries).

Conclusion: CTS + EC provided effective immobilization with low complication rate, and functional outcomes were favorable even in active dogs.

🔍 Key Findings

• Double-loop cerclage resisted the highest peak load (805 N) and maintained tension longer than twist (488 N) and single-loop (397 N) configurations.
• Double-loop cerclage sustained 500,000 cycles at 60–80% of peak load in some cases without loosening, outperforming other types.
• Twist knots loosened rapidly, often within 10 cycles even at low loads (100–390 N).
• Single-loop knots performed better than twist, with partial resistance up to 100,000 cycles at 160 N, but showed wide variability.
• All loosening occurred before wire breakage, indicating clinical failure would happen from slack, not fracture.
• Double-loop cerclage had highest initial tension (323 N) compared to single-loop (124 N) and twist (69 N).
• Fatigue limit was not identified for twist, since they all loosened early at even 20% of peak load.
• Clinical recommendation: double-loop cerclage is best for resisting repeated subfailure loading, ideal for fissure prevention or fragment stabilization.

🔍 Key Findings

Objective: Determine if topical 45 mg/mL amikacin in CMC gel leads to systemic absorption in dogs with wounds.

Dogs enrolled: 11 client-owned dogs, with 31 applications of the gel.

Serum findings:

• Only 5 of 153 samples were above the 2.5 µg/mL quantification limit
• All values remained <5 µg/mL, the presumed toxicity threshold
• No correlation was found between dose-related parameters (mg, mg/kg, mg/cm²) and serum amikacin levels

Peak concentrations were observed at ~2 hours post-application, declining rapidly thereafter

No nephrotoxicity observed, and most values were below detection

Conclusion: Topical amikacin gel appears safe at doses up to 24.9 mg/kg, with minimal systemic absorption

🔍 Key Findings

• Zurich mini-cementless THA was successful in 9/10 hips in dogs <4 kg, with no lameness at 52 weeks in completed cases.
• Helsinki Chronic Pain Index significantly improved from a mean of 19.8 to 2.3 at 52 weeks (p = 0.0141).
• Fluoroscopy improved implant positioning, especially in LCPD and HD cases, aiding in accurate reaming and alignment.
• Intraoperative complications occurred in 2/10 cases, including acetabular fractures; one case required discontinuation.
• Prophylactic bicortical screws and reinforcement plates were used in cases with rotational instability or cortical compromise and were effective in preventing loosening/fractures.
• Medial patellar luxation improved postoperatively in one dog, though recurrence was noted later without surgical correction.
• No stem or implant loosening or fracture occurred over a mean follow-up of 24.4 months.
• CT is recommended in preoperative planning, particularly in luxoid hip dysplasia cases with uncertain bone stock.

🔍 Key Findings

• TPLO alone failed to neutralize rotational instability under tibial pivot compression (TPT), despite a negative TCT.
• TPLO combined with lateral augmentation (TPLO-IB) restored both craniocaudal and rotational stability to near-intact levels.
• Cranial tibial translation was 6× greater after TPLO vs intact stifles when tested with TPT (p < .001).
• No significant difference in cranial tibial translation or internal rotation between intact stifles and TPLO-IB group during TCT, eTPT, or iTPT.
• TPLO-IB did not overconstrain the stifle, avoiding excessive external rotation.
• External tibial rotation (eTPT) was more sensitive than TCT in detecting persistent instability after TPLO.
• Excellent intraobserver reliability for both eTPT and iTPT (ICC > 0.9).
• Study supports intraoperative use of TPT to identify cases needing additional rotational stabilization.

🔍 Key Findings

Source: Bush et al., 2023, Veterinary Surgery

• Median survival time (MST) after surgery was 1886 days, which is significantly longer than previously reported.
• Lymph node metastasis at surgery was a negative prognostic factor, reducing MST to 248 days (vs. 2340 days without nodal involvement).
• Local recurrence occurred in 42% of dogs, with a median disease-free interval (DFI) of 191 days.
• Metastatic disease occurred in 32% of dogs, most commonly to the lungs, with a median DFI of 299 days.
• Histologic features (e.g., margin status, capsular, lymphatic, or vascular invasion) were not significantly correlated with recurrence or metastasis.
• Facial nerve injury occurred in 9.7% perioperatively, especially after parotidectomy; intraoperative facial nerve transection led to long-term deficits.
• Adjuvant therapies (chemotherapy, radiation, NSAIDs) did not significantly affect survival time.
• Incisional biopsy was only 38% concordant with final excisional histology, suggesting limited reliability for definitive diagnosis.

🔍 Key Findings

• Arthroscopic meniscal suturing was performed in 43 client-owned dogs, involving 44 meniscal repairs (one dog was bilateral). All injuries involved the caudal horn of the medial meniscus and were associated with cranial cruciate ligament (CrCL) disease.
• All dogs underwent simultaneous TPLO, with some also receiving an internal brace (IB). Most repairs used simple vertical mattress sutures.
• The overall complication rate was 34.1% (15/44). Most complications were attributed to the TPLO/TPLO+IB and did not compromise the meniscal repair outcome.
• No median time to “acceptable” or “full” function was reported, but most dogs showed improvement in lameness and LOAD scores (p < .001), indicating good to excellent outcomes.
• Meniscal repair success rate was 88% (38/44), with TPLO + IB outperforming TPLO-only (93.3% vs 71.4%). Follow-up was performed at 8 weeks (40 dogs) and 6 months (16 dogs).
• Six failures occurred, all managed with arthroscopic meniscectomy, leading to normal activity in those dogs. Two IB-associated failures led to CrCL instability.
• The authors concluded the technique was safe, practical, and effective, with a reasonable complication rate.
• The findings support arthroscopic suturing as a feasible alternative to meniscectomy or meniscal release, offering long-term benefits for preserving the meniscus.

🔍 Key Findings

• 20 dogs (26 shoulders) evaluated at mean 3.5 years post-surgery after arthroscopic or open debridement.
• Ipsilateral muscle atrophy and decreased range of motion (↓ extension, ↓ flexion) in affected limbs compared to contralateral healthy shoulders.
• All treated shoulders developed osteoarthritis, confirmed radiographically, by CT, and arthroscopically.
• Moderate to severe synovitis was present in all shoulders; lesions showed patchy, incomplete cartilage infilling even up to 8.9 years post-op.
• Kinetic gait analysis showed no significant differences in PVF/VI between affected and unaffected limbs, despite mild lameness clinically.
• Owners reported good to very good mobility (median LOAD = 6), often underestimating clinical lameness.
• CT detected larger lesion dimensions than radiographs (wider, deeper defects).
• Despite progression of OA, surgical debridement was associated with satisfactory long-term function, though not prevention of degenerative changes.